|1.||Belani, Chandra P: 1 article (12/2011)|
|2.||Valdivieso, Manuel: 1 article (12/2011)|
|3.||Heath, Elisabeth I: 1 article (12/2011)|
|4.||Besse-Hamer, Tatiana: 1 article (12/2011)|
|5.||Awada, Ahmad: 1 article (12/2011)|
|6.||Cardoso, Fatima: 1 article (12/2011)|
|7.||Zhou, Xiaofei: 1 article (12/2011)|
|8.||Has, Teresa: 1 article (12/2011)|
|9.||Alland, Leila: 1 article (12/2011)|
|10.||Egorin, Merrill J: 1 article (12/2011)|
12/01/2011 - "The present study was designed to: (i) assess the safety and tolerability of BMS-275183, and (ii) determine a suitable Phase II dose of BMS-275183 when given on a continuous daily schedule to patients with advanced solid tumor(s). "
09/01/2007 - "BMS-275183 is an orally bioavailable taxane that has antitumor activity in preclinical cancer models. "
11/01/2004 - "The combination of oral taxane BMS-275183 plus cetuximab provided therapeutically synergistic antitumor activity in two different human tumor xenograft models. "
11/01/2004 - "Therapeutic synergy of oral taxane BMS-275183 and cetuximab versus human tumor xenografts."
11/01/2004 - "Combination therapy consisting of an oral taxane, BMS-275183, and the anti-epidermal growth factor receptor monoclonal antibody, cetuximab, was assessed for enhanced therapeutic benefit in preclinical tumor models. "
|2.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
|4.||Breast Neoplasms (Breast Cancer)
12/01/2002 - "To examine this hypothesis, we assessed the effects of several different chemotherapeutic drugs--namely paclitaxel, 4-hydroperoxycyclophosphamide, BMS-275183 (an oral taxane), doxorubicin, epothilone B (EpoB) and its analogue 5-methylpyridine EpoB--on human microvascular or macrovascular endothelial cells, fibroblasts, and drug-sensitive or multidrug-resistant breast cancer cell lines in cell culture, using both short-term (24 h) versus long-term (144 h), continuous exposures, where drug-containing medium was replaced every 24 h. "
|3.||Epidermal Growth Factor Receptor (EGF Receptor)
|6.||epothilone B (EPO906)
|1.||Heterologous Transplantation (Xenotransplantation)